Pharmaceuticals including protein-based and other pharmaceuticals for use in treating diseases, including inflammatory diseases, chronic skin ulcers, neurological disorders, rheumatoid arthritis, sepsis and septic shock, leukemia, cystic fibrosis, genetic emphysema, peripheral neuropathies, sepsis syndrome, systemic inflammatory reponse syndrome (SIRS), pancreatitis, burns and cachexia, asthma, inflammatory bowel disease, graft versus host disease, stroke and IL-1 mediated diseases; and all other goods in this class